Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia

Cardiac iron overload causes most deaths in beta-thalassemia major. The efficacy of deferasirox in reducing or preventing cardiac iron overload was assessed in 192 patients with beta-thalassemia in a 1-year prospective, multicenter study. The cardiac iron reduction arm (n = 114) included patients wi...

Full description

Bibliographic Details

Main Authors:	Pennell, D.J., Porter, J.B., Cappellini, M.D., El-Beshlawy, A., Chan, L.L., Aydinok, Y., Elalfy, M.S., Sutcharitchan, P., Li, C.K., Ibrahim, H., Viprakasit, V., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Format:	Article
Published:	2010
Subjects:	R Medicine
Online Access:	http://eprints.um.edu.my/14976/
Tags:	Add Tag No Tags, Be the first to tag this record!